Wellements Baby Move Prune Concentrate Recall Issued Due to Salmonella

Concerns about a potential risk of salmonella food poisoning have led to a recall of Wellement’s Baby Move Prune Concentrate, an infant dietary supplement. 

The prune concentrate recall was announced on July 20, after a supplier determined that one of the ingredients may be contaminated with salmonella. However, there have been no illnesses reported in connection to the recall.

Baby Move Prune Concentrate is a liquid dietary supplement manufactured by Wellements LLC, which was informed on July 13 that an ingredient called Purimune, supplied by Ingredion, tested positive for salmonella. So far, no actual lots of Baby Move have tested positive for salmonella contamination.

Hair-Dye-Cancer-Lawsuits
Hair-Dye-Cancer-Lawsuits

The recall affects all lots of Wellements Baby Move Prune Concentrate, 4 oz, up to and including lot number 12179. The recalled dietary supplement comes in a glass bottle and is packaged in an individual carton with UPC 729609019878. It was sold from January 2012 to July 2012 nationwide online and through retail stores.

Salmonella is a type of bacteria that attacks the gastrointestinal tract, causing mild to severe food poisoning. For most healthy adults, symptoms of food poisoning from salmonella typically resolve after a few days or weeks. However, young children face an increased risk of suffering severe food poisoning after ingesting the bacteria. If not properly treated, some cases of salmonella food poisoning can lead to hospitalization, dehydration or death.

The FDA and Wellements LLC recommend that consumers who have purchased the affected Baby Move Prune Concentrate return it to the place of purchase for a full refund. Consumers with questions can call Wellements LLC at (800) 255-2690 ext. 210.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025.
Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case.
An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe.